(R)-(-)-1-Aminoindane CAS 10277-74-4 Purity >98.0% (GC) E.E >98.0%

Short Description:

Chemical Name: (R)-(-)-1-Aminoindane

CAS: 10277-74-4

Purity: >98.0% (GC)  

Chiral Purity (e.e.): >98.0%

Appearance: Colorless or Yellow Liquid 

Contact: Dr. Alvin Huang

Mobile/Wechat/WhatsApp: +86-15026746401

E-Mail: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Description:

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of (R)-(-)-1-Aminoindane (CAS: 10277-74-4) with high quality. We can provide COA, worldwide delivery, small and bulk quantities available. If you are interested in this product, please send detailed information includes CAS number, product name, quantity to us. Please contact: alvin@ruifuchem.com

Chemical Properties:

Chemical Name (R)-(-)-1-Aminoindane  
Synonyms (R)-1-Aminoindane; (R)-(-)-1-Indanamine; (1R)-Indan-1-Amine; (R)-1-Indanylamin; (R)-2,3-Dihydro-1H-Inden-1-Amine; (1R)-2,3-Dihydro-1H-Inden-1-Amine; (R)-2,3-Dihydro-1-Indenamine 
CAS Number 10277-74-4 
CAT Number RF-CC358
Stock Status In Stock, Production Scale Up to Tons
Molecular Formula C9H11N 
Molecular Weight 133.19 
Melting Point 15℃ (lit.)
Boiling Point 96.0~97.0℃/8 mmHg (lit.) 
Density 1.038 g/mL at 25℃(lit.)
Refractive Index n20/D 1.562 (lit.) 
Sensitive Air Sensitive 
Solubility  Soluble in Methanol. Not Miscible or Difficult to Mix in Water
Brand Ruifu Chemical

Specifications:

Item Specifications
Appearance Colorless or Yellow Liquid
Purity / Analysis Method >98.0% (GC) 
Chiral Purity (E.E.) >98.0%
Specific Rotation [α]20/D  -18.0° ~ -15.0° (C=1.5% in MeOH)
Total Impurities <2.00%
Infrared Spectrum Conforms to Structure
Proton NMR Spectrum Conforms to Structure
Test Standard Enterprise Standard
Usage Chiral Compound; Pharmaceutical Intermediates

Package & Storage:

Package: Fluorinated Bottle, 25kg/Drum, or according to customer's requirement

Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moisture

Advantages:

Sufficient Capacity: Sufficient facilities and technicians

Professional Service: One stop purchasing service

OEM Package: Custom package and label available

Fast Delivery: If within stock, three days delivery guaranteed

Stable Supply: Maintain reasonable stock    

Technical Support: Technology solution available

Custom Synthesis Service: Ranged from grams to kilos

High Quality: Established a complete quality assurance system

FAQ:

How to Purchase? Please contact Dr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com 

15 Years Experience? We have more than 15 years of experience in the manufacture and export of a wide range of high quality pharmaceutical intermediates or fine chemicals.

Main Markets? Sell to domestic market, North America, Europe, India, Korea, Japanese, Australia, etc.

Advantages? Superior quality, affordable price, professional services and technical support, fast delivery.

Quality AssuranceStrict quality control system. Professional equipment for analysis include NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, K.F, ROI, LOD, MP, Clarity, Solubility, Microbial limit test, etc.

SamplesMost products provide free samples for quality evaluation, shipping cost should be paid by customers.

Factory AuditFactory audit welcome. Please make an appointment in advance.

MOQ? No MOQ. Small order is acceptable.

Delivery Time? If within stock, three days delivery guaranteed.

TransportationBy Express (FedEx, DHL), by Air, by Sea.

Documents? After sales service: COA, MOA, ROS, MSDS, etc. can be provided.

Custom SynthesisCan provide custom synthesis services to best fit your research needs.

Payment TermsProforma invoice will be sent first after confirmation of order, enclosed our bank information. Payment by T/T (Telex Transfer), PayPal, Western Union, etc. 

Application:

(R)-(-)-1-Aminoindane (CAS: 10277-74-4) is an impurity or intermediate of Rasagiline (CAS: 136236-51-6) or Rasagiline Mesylate (CAS: 161735-79-1). Rasagiline Mesylate is a potent and selective irreversible monoamine oxidase B (MAO-B) inhibitor launched in 2005 in Israel by Teva as monotherapy in patients with early Parkinson's disease and as adjuvant treatment in moderate-toadvanced disease. Lundbeck will market the drug throughout Europe. Rasagiline is in phase II clinical trials at Teva and Eisai for the treatment of Alzheimer's type dementia.

  • Write your message here and send it to us